한글목차

일본의 디지털 병리학 시장 규모는 2023년 3,611만 달러로 추정됩니다. 향후 IMARC 그룹은 2032년까지 시장 규모가 1억 1,834만 달러에 달하고, 2024년부터 2032년까지 13.50%의 연평균 성장률(CAGR)을 나타낼 것으로 예측했습니다. 주요 기업들의 헬스케어 기술에 대한 광범위한 투자가 시장 성장의 주요 원동력이 되고 있습니다.

본 보고서에서 다룬 주요 질문

• 일본의 디지털 병리학 시장은 지금까지 어떻게 성장해왔고, 앞으로 어떻게 발전할 것인가?
• 코로나19가 일본 디지털 파소로지 시장에 미치는 영향은?
• 일본 디지털 병리학 시장의 제품별 현황은?
• 일본의 디지털 병리학 시장 유형별 분류는?
• 일본 디지털 병리학 시장의 제공 모델별 현황은?
• 일본 디지털 패슬로지 시장의 용도별 현황은?
• 일본 디지털 병리학 시장의 최종 사용자별 현황은?
• 일본 디지털 파소로지 시장의 가치사슬에는 어떤 단계가 있는가?
• 일본의 디지털 병리학의 주요 촉진요인과 과제는?
• 일본 디지털 병리학 시장의 구조와 주요 기업은?
• 일본 디지털 병리학 시장에서의 경쟁은 어느 정도인가?

목차

제1장 서문

제2장 조사 범위와 조사 방법

• 조사 목적
• 이해관계자
• 데이터 소스
• 시장 추정
• 조사 방법

제3장 주요 요약

제4장 일본의 디지털 병리학 시장 - 서론

• 개요
• 시장 역학
• 업계 동향
• 경쟁 정보

제5장 일본의 디지털 병리학 시장 구도

• 과거 및 현재 시장 동향(2018-2023년)
• 시장 예측(2024-2032년)

제6장 일본의 디지털 병리학 시장 : 제품별 분석

• 스캐너
• 소프트웨어
• 스토리지 시스템
• 통신 시스템

제7장 일본의 디지털 병리학 시장 : 유형별 분석

• 인간 병리학
• 수의 병리학

제8장 일본의 디지털 병리학 시장 : 제공 모델별 분석

• 온프레미스
• 호스티드

제9장 일본의 디지털 병리학 시장 : 용도별 분석

• 연수 및 교육
• 컨설팅 서비스
• 수술 중 상담
• 정기 진단 상담 서비스
• 기타

제10장 일본의 디지털 병리학 시장 : 최종사용자별 분석

• 제약 기업 및 바이오테크놀러지 기업
• 병원 및 참조 실험실
• 학술연구기관

제11장 일본의 디지털 병리학 시장 : 경쟁 구도

• 개요
• 시장 구조
• 시장 기업 포지셔닝
• 주요 성공 전략
• 경쟁 대시보드
• 기업 평가 상한

제12장 주요 기업 개요

제13장 일본의 디지털 병리학 시장 : 업계 분석

• 성장 촉진요인 및 억제요인과 기회
• Porter의 Five Forces 분석
• 밸류체인 분석

제14장 부록

영문목차

Japan digital pathology market size reached US$ 36.11 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 118.34 Million by 2032, exhibiting a growth rate (CAGR) of 13.50% during 2024-2032. The widespread investments by key players in the healthcare technologies are primarily driving the market growth.

Digital pathology is a cutting-edge medical technology that revolutionizes the traditional practice of examining tissue samples for disease diagnosis. Instead of using conventional glass slides, digital pathology involves the digitization of tissue samples into high-resolution images. These digital images are then stored, analyzed, and shared electronically, enabling pathologists and medical professionals to collaborate and make diagnoses remotely. Digital pathology offers numerous advantages, including improved accuracy, speed, and efficiency in diagnosing diseases such as cancer. It also facilitates the integration of artificial intelligence and machine learning algorithms, which can assist in automating certain aspects of image analysis and enhancing diagnostic precision. Additionally, digital pathology allows for the creation of extensive digital archives, enabling researchers to access and study a vast repository of medical data for various purposes, including medical research, education, and quality assurance in healthcare settings.

Japan Digital Pathology Market Trends:

The digital pathology market in Japan is witnessing significant growth and transformation within the country's healthcare landscape. Japan, known for its technological advancements, is embracing digital pathology as a powerful tool to enhance disease diagnosis and patient care. The adoption of this technology streamlines the process of tissue sample analysis by digitizing pathology slides, allowing for remote collaboration among pathologists and enabling faster and more accurate diagnoses. With a growing aging population, the demand for precise and timely pathology services is increasing, making digital pathology an invaluable asset in managing healthcare needs efficiently. Additionally, the integration of artificial intelligence and machine learning into digital pathology systems is enhancing diagnostic capabilities further. These innovations not only improve diagnostic accuracy but also help address the challenges posed by a shortage of pathologists in the country. As Japan continues to invest in healthcare technologies, the digital pathology market is poised for continued growth and innovation to meet the evolving demands of the healthcare sector.

Japan Digital Pathology Market Segmentation:

Product Insights:

• Scanners
• Software
• Storage Systems
• Communication Systems

Type Insights:

• Human Pathology
• Veterinary Pathology

Delivery Model Insights:

• On-premises
• Hosted

Application Insights:

• Training and Education
• Consulting Services
• Intraoperative Consultation
• Routine Diagnostic Consultation Services
• Others

End User Insights:

• Pharmaceutical and Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic and Research Institutes

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan digital pathology market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan digital pathology market?
• What is the breakup of the Japan digital pathology market on the basis of product?
• What is the breakup of the Japan digital pathology market on the basis of type?
• What is the breakup of the Japan digital pathology market on the basis of delivery model?
• What is the breakup of the Japan digital pathology market on the basis of application?
• What is the breakup of the Japan digital pathology market on the basis of end user?
• What are the various stages in the value chain of the Japan digital pathology market?
• What are the key driving factors and challenges in the Japan digital pathology?
• What is the structure of the Japan digital pathology market and who are the key players?
• What is the degree of competition in the Japan digital pathology market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Digital Pathology Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Digital Pathology Market Landscape

• 5.1 Historical and Current Market Trends (2018-2023)
• 5.2 Market Forecast (2024-2032)

6 Japan Digital Pathology Market - Breakup by Product

• 6.1 Scanners
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2018-2023)
  • 6.1.3 Market Forecast (2024-2032)
• 6.2 Software
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2018-2023)
  • 6.2.3 Market Forecast (2024-2032)
• 6.3 Storage Systems
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2018-2023)
  • 6.3.3 Market Forecast (2024-2032)
• 6.4 Communication Systems
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2018-2023)
  • 6.4.3 Market Forecast (2024-2032)

7 Japan Digital Pathology Market - Breakup by Type

• 7.1 Human Pathology
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2018-2023)
  • 7.1.3 Market Forecast (2024-2032)
• 7.2 Veterinary Pathology
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2018-2023)
  • 7.2.3 Market Forecast (2024-2032)

8 Japan Digital Pathology Market - Breakup by Delivery Model

• 8.1 On-premises
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2018-2023)
  • 8.1.3 Market Forecast (2024-2032)
• 8.2 Hosted
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2018-2023)
  • 8.2.3 Market Forecast (2024-2032)

9 Japan Digital Pathology Market - Breakup by Application

• 9.1 Training and Education
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2018-2023)
  • 9.1.3 Market Forecast (2024-2032)
• 9.2 Consulting Services
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2018-2023)
  • 9.2.3 Market Forecast (2024-2032)
• 9.3 Intraoperative Consultation
  • 9.3.1 Overview
  • 9.3.2 Historical and Current Market Trends (2018-2023)
  • 9.3.3 Market Forecast (2024-2032)
• 9.4 Routine Diagnostic Consultation Services
  • 9.4.1 Overview
  • 9.4.2 Historical and Current Market Trends (2018-2023)
  • 9.4.3 Market Forecast (2024-2032)
• 9.5 Others
  • 9.5.1 Historical and Current Market Trends (2018-2023)
  • 9.5.2 Market Forecast (2024-2032)

10 Japan Digital Pathology Market - Breakup by End User

• 10.1 Pharmaceutical and Biotechnology Companies
  • 10.1.1 Overview
  • 10.1.2 Historical and Current Market Trends (2018-2023)
  • 10.1.3 Market Forecast (2024-2032)
• 10.2 Hospitals and Reference Laboratories
  • 10.2.1 Overview
  • 10.2.2 Historical and Current Market Trends (2018-2023)
  • 10.2.3 Market Forecast (2024-2032)
• 10.3 Academic and Research Institutes
  • 10.3.1 Overview
  • 10.3.2 Historical and Current Market Trends (2018-2023)
  • 10.3.3 Market Forecast (2024-2032)

11 Japan Digital Pathology Market - Competitive Landscape

• 11.1 Overview
• 11.2 Market Structure
• 11.3 Market Player Positioning
• 11.4 Top Winning Strategies
• 11.5 Competitive Dashboard
• 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

• 12.1 Company A
  • 12.1.1 Business Overview
  • 12.1.2 Product Portfolio
  • 12.1.3 Business Strategies
  • 12.1.4 SWOT Analysis
  • 12.1.5 Major News and Events
• 12.2 Company B
  • 12.2.1 Business Overview
  • 12.2.2 Product Portfolio
  • 12.2.3 Business Strategies
  • 12.2.4 SWOT Analysis
  • 12.2.5 Major News and Events
• 12.3 Company C
  • 12.3.1 Business Overview
  • 12.3.2 Product Portfolio
  • 12.3.3 Business Strategies
  • 12.3.4 SWOT Analysis
  • 12.3.5 Major News and Events
• 12.4 Company D
  • 12.4.1 Business Overview
  • 12.4.2 Product Portfolio
  • 12.4.3 Business Strategies
  • 12.4.4 SWOT Analysis
  • 12.4.5 Major News and Events
• 12.5 Company E
  • 12.5.1 Business Overview
  • 12.5.2 Product Portfolio
  • 12.5.3 Business Strategies
  • 12.5.4 SWOT Analysis
  • 12.5.5 Major News and Events

13 Japan Digital Pathology Market - Industry Analysis

• 13.1 Drivers, Restraints, and Opportunities
  • 13.1.1 Overview
  • 13.1.2 Drivers
  • 13.1.3 Restraints
  • 13.1.4 Opportunities
• 13.2 Porters Five Forces Analysis
  • 13.2.1 Overview
  • 13.2.2 Bargaining Power of Buyers
  • 13.2.3 Bargaining Power of Suppliers
  • 13.2.4 Degree of Competition
  • 13.2.5 Threat of New Entrants
  • 13.2.6 Threat of Substitutes
• 13.3 Value Chain Analysis

14 Appendix